Principal investigators and laboratory researchers seeking to buy high-purity Chonluten for proinflammatory cytokine inhibition studies require batch-specific analytical validation and strict peptide purity. PX1 Research supplies research-grade Chonluten (Glu-Asp-Gly) synthesized under rigid quality controls for in vitro and preclinical experimental assays.
Principal investigators and laboratory researchers seeking to buy high-purity Chonluten for proinflammatory cytokine inhibition studies require batch-specific analytical validation and strict peptide purity. PX1 Research supplies research-grade Chonluten (Glu-Asp-Gly) synthesized under rigid quality controls for in vitro and preclinical experimental assays.
When purchasing research-grade Chonluten to investigate proinflammatory cytokine inhibition, institutional laboratories require fully characterized tripeptide sequences devoid of residual TFA, heavy metals, or bacterial endotoxins. Chonluten—a short-chain bioregulatory peptide composed of L-glutamic acid, L-aspartic acid, and L-glycine (Glu-Asp-Gly)—is evaluated in cellular and animal models for its capacity to modulate inflammatory cascades, specifically downregulating IL-1β, IL-6, and TNF-α expression.
PX1 Research provides fully documented Chonluten peptide accompanied by lot-specific Certificates of Analysis (COAs), verified via high-performance liquid chromatography (HPLC) and mass spectrometry (MS). Every lot is manufactured in US-based, GMP-compliant facilities to ensure absolute inter-batch consistency across complex cellular and biochemical assays.
Chonluten is a synthetic tripeptide characterized by the primary amino acid sequence H-Glu-Asp-Gly-OH. With a molecular formula of C11H17N3O8 and a low molecular weight of approximately 303.27 g/mol, its small hydrodynamic radius allows it to interact directly with chromatin structures and specific intracellular receptors within cell culture models.
In biochemical investigations, short bioregulatory peptides like Chonluten are synthesized using solid-phase peptide synthesis (SPPS) protocols. The carboxyl-terminal glycine and amino-terminal glutamic acid residues establish specific spatial conformations that facilitate electrostatic binding to double-stranded DNA grooves. Researchers evaluating all peptides in the short-chain bioregulator family leverage this low molecular mass to examine rapid cell membrane permeability without requiring specialized delivery vectors in culture media.
Preclinical literature demonstrates that Chonluten exhibits targeted activity in modulating the transcriptional machinery responsible for acute and chronic inflammatory responses. In vitro data indicate that exposure to Chonluten suppresses nuclear factor kappa B (NF-κB) nuclear translocation within macrophages and epithelial cells. Because NF-κB serves as the master transcriptional regulator for proinflammatory cytokines, its inhibition directly attenuates the downstream synthesis of tumor necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β), and interleukin-6 (IL-6).
Furthermore, animal models investigating acute pulmonary inflammation suggest that administration of Chonluten reduces neutrophil accumulation in bronchoalveolar lavage fluid (BALF). This suppression of hyper-inflammatory signaling is hypothesized to occur via epigenetic modulation: the tripeptide binds histone proteins or promoter regions of specific cytokine genes, dampening hyper-reactive gene expression during stress state induction. Researchers looking to explore broader systemic inflammatory pathways frequently cross-reference these findings with our extensive research library.
Unlike large monoclonal antibodies that neutralize cytokines outside the cell, short peptide bioregulators like Chonluten act upstream at the chromatin level. Molecular docking studies suggest that Glu-Asp-Gly selectively binds to specific nucleotide sequences (such as CATT or TATC regions) in promoter sites of heat shock proteins and cytokine genes.
In senescent or LPS-challenged cell culture lines, this sequence-specific binding alters local chromatin density, restoring physiological baseline transcription levels. By dampening the over-expression of proinflammatory mediators while preserving baseline immune signaling, Chonluten serves as an ideal reference compound for studying fine-tuned epigenetic control over cellular inflammation.
When designing comparative protocols targeting cytokine attenuation or tissue homeostasis, researchers often evaluate Chonluten alongside related short-chain regulatory peptides. Understanding structural and functional distinctions between these compounds allows investigators to select the precise molecular tool for their primary endpoint.
While Chonluten focuses primarily on respiratory epithelial homeostasis and nuclear cytokine suppression, Bronchogen (Ala-Glu-Asp-Pro) targets bronchial cell proliferation directly. For studies prioritizing localized gastrointestinal or mucosal cytokine down-regulation, investigators frequently implement tripeptides like KPV (Lys-Pro-Val). Additionally, broad-spectrum immune signaling models often pair tripeptides with thymic fractions such as Thymalin to evaluate synergistic T-cell receptor expression alongside proinflammatory cytokine clearance.
Achieving reproducible concentrations in cellular assays requires strict adherence to analytical reconstitution standards. Chonluten is supplied as a lyophilized white powder under vacuum seal to prevent premature hydrolysis.
For primary stock solutions, researchers typically solubilize Chonluten using sterile, nuclease-free water or phosphate-buffered saline (PBS, pH 7.4). Due to the acidic nature of the glutamic and aspartic acid side chains, initial dissolution in neutral aqueous buffers yields high solubility (>10 mg/mL). Avoid vigorous vortexing; gentle inversion or mild end-over-end agitation is recommended to maintain molecular integrity before diluting into complete cell culture medium.
To ensure long-term integrity, unopened lyophilized vials of Chonluten must be stored at -20°C or -80°C in a desiccated environment. Under sub-zero conditions, the dry peptide remains stable for up to 24 months without significant degradation of the primary sequence.
Once reconstituted into aqueous liquid stocks, aliquots should be prepared immediately to avoid repeated freeze-thaw cycles. Reconstituted solutions maintained at 4°C should be utilized within 7 to 14 days, whereas frozen aliquots stored at -80°C preserve stability for up to 6 months. Exposure to ambient room temperature or direct light should be minimized during liquid handling steps.
Research evaluating fine proinflammatory cytokine pathways requires absolute certainty regarding compound identity and purity. Trace endotoxins or residual organic solvents can trigger non-specific inflammatory signaling in cell culture, skewing experimental readings and invalidating cytokine assays.
PX1 Research subjects every batch of Chonluten to rigorous analytical verification. Replicate samples undergo Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) to confirm purity exceeding 99.0%, alongside Electrospray Ionization Mass Spectrometry (ESI-MS) to confirm exact molecular mass. Furthermore, every lot is tested via Chromogenic Limulus Amebocyte Lysate (LAL) assays to ensure endotoxin levels remain strictly below <0.01 EU/mg, protecting cell assays from confounding lipopolysaccharide responses.
Selecting a reliable supplier for research-grade peptides demands vendor transparency, verified manufacturing processes, and dependable logistics. PX1 Research operates exclusively as an institutional vendor, supplying pure compounds intended solely for in vitro and preclinical laboratory research.
All products are manufactured within US-based GMP-compliant facilities and tested by independent ISO 17025 accredited laboratories. For high-throughput screening or multi-phase animal studies, qualified researchers can establish streamlined supply channels through our dedicated wholesale program. Orders are dispatched same-day (Monday–Friday) from regional logistics centers in California and Arizona to prevent experimental delays.
What is Chonluten studied for in cellular models?
Chonluten (Glu-Asp-Gly) is evaluated in preclinical research for its capacity to regulate respiratory epithelial gene expression, alter chromatin structure, and attenuate the production of proinflammatory cytokines such as IL-1β, IL-6, and TNF-α.
What purity level does PX1 Research guarantee for Chonluten?
Every lot of Chonluten provided by PX1 Research is verified by RP-HPLC and Mass Spectrometry to meet or exceed 99.0% peptide purity, with detailed COAs provided for independent review.
How is endotoxin testing performed on Chonluten batches?
PX1 Research subjects all peptide lots to LAL (Limulus Amebocyte Lysate) endotoxin testing. Chonluten batches are verified to contain <0.01 EU/mg of endotoxin to eliminate confounding baseline inflammatory triggers in cell culture assays.
What solvents are suitable for reconstituting Chonluten for in vitro assays?
Chonluten reconstitutes readily in sterile nuclease-free water or standard phosphate-buffered saline (PBS, pH 7.4). For working culture media, stock solutions can be diluted directly into DMEM or RPMI.
How should reconstituted Chonluten stock solutions be stored?
Reconstituted liquid stock aliquots should be stored at -80°C for long-term stability (up to 6 months) or kept at 4°C for short-term experimental workflows (up to 14 days). Multiple freeze-thaw cycles must be avoided.
Is Chonluten approved for human therapeutic use or clinical dosing?
No. Chonluten supplied by PX1 Research is strictly a research compound manufactured for laboratory in vitro and preclinical experimental investigation only. It is not for human or veterinary consumption, medical treatment, or therapeutic use.
What related bioregulatory peptides are available for comparative cytokine assays?
Researchers frequently compare Chonluten alongside other short-chain peptides such as Bronchogen (Ala-Glu-Asp-Pro), KPV (Lys-Pro-Val), and Thymalin fractions to evaluate distinct structural impacts on inflammatory pathways.
Where are PX1 Research products manufactured and shipped from?
PX1 Research peptides are manufactured in US-based GMP-compliant facilities and shipped directly from fulfillment centers located in California and Arizona, with same-day dispatch for orders placed Monday through Friday.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.